Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway

Immunity

Volumn 15, Issue 1, 2001, Pages 15-22

  Garren, Hideki ^a,b   Ruiz, Pedro J ^a,b   Watkins, Trent A ^a   Fontoura, Paulo ^a   Nguyen, Louis Vu T ^a   Estline, Einat R ^a   Hirschberg, David L ^a   Steinman, Lawrence ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b SunVax Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; INTERLEUKIN 4; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PLASMID DNA; PROTEOLIPID PROTEIN; STAT6 PROTEIN;

ACTIVE IMMUNIZATION; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE TARGETING; GENETIC CODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; TH1 CELL; TH2 CELL;

EID: 0034897403     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00171-6     Document Type: Article

References (28)

1. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis
2. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2
3. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes
4. DNA vaccination in the treatment of autoimmune disease
5. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids
6. Activity and safety of DNA plasmids encoding IL-4 and IFN gamma
7. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen
8. Modulation of amplitude and direction of in vivo immune responses by coadministration of cytokine gene expression cassettes with DNA immunogens
9. Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV
10. Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice
11. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen
12. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis
13. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis
14. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent
15. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations
16. Manipulation of the Th1/Th2 balance in autoimmune disease
17. Interleukin 4: Signalling mechanisms and control of T cell differentiation
18. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis
19. DNA vaccines
20. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: Modulation of T cell costimulation
21. Escape from "horror autotoxicus": Pathogenesis and treatment of autoimmune disease
22. Essential role of Stat6 in IL-4 signalling
23. Genetic immunization is a simple method for eliciting an immune response
24. Epitope spreading
25. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity
26. Differential recognition of MBP epitopes in BALB/c mice determines the site of inflammatory disease induction
27. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease
28. The T lymphocyte in experimental allergic encephalomyelitis